文献速递胸部CTPET

减影CT氙增强CT与双能CT及通气SPECT/CT评估吸烟者区域通气及肺功能损失效能的初步临床比较研究

Xenon-enhanced CT using subtraction CT: Basic and preliminary clinical studies for comparison of its efficacy with that of dual-energy CT and ventilation SPECT/CT to assess regional ventilation and pulmonary functional loss in smokers.
PubMed 文献 · Eur J Radiol · 2016-11-02

前瞻性纳入23名连续吸烟者,对比减影CT与双能CT氙增强CT及通气SPECT/CT评估区域通气和肺功能损失的能力;三种方法观察者间一致性均为中等(κ=0.69、0.64、0.64),功能肺容积与%FEV1呈显著至良好相关(r=0.72、0.74、0.66);减影CT效能至少不劣于双能CT和SPECT/CT。

要点

  • 减影CT氙增强CT评估吸烟者通气异常和肺功能损失,效能至少不劣于双能CT和SPECT/CT。
  • 减影CT、双能CT和SPECT/CT的观察者间一致性均为中等(κ分别为0.69、0.64、0.64)。
  • 减影CT功能肺容积与%FEV1相关系数r=0.72,双能CT r=0.74,SPECT/CT r=0.66。

核心结论

  • 减影CT氙增强CT在评估吸烟者通气异常和肺功能损失方面,效能至少不劣于双能CT和SPECT/CT。

研究设计与样本

  • 前瞻性研究,连续纳入23名吸烟者(15男8女,平均年龄69.7±8.7岁),均行减影CT和双能CT氙增强CT、通气SPECT及肺功能检查;以11分评分系统按肺叶评估区域通气,并与%FEV1相关分析。

诊断标准与关键数值

  • 观察者间一致性加权κ值:减影CT κ=0.69(p<0.0001),双能CT κ=0.64(p<0.0001),SPECT/CT κ=0.64(p<0.0001),均评为中等一致性;功能肺容积与%FEV1相关系数:减影CT r=0.72(p=0.0001),双能CT r=0.74(p<0.0001),SPECT/CT r=0.66(p=0.0006)。

临床应用与阅片要点

  • 作者认为减影CT氙增强CT可考虑用于评估吸烟者通气异常和肺功能损失,效能至少不劣于双能CT和SPECT/CT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To prospectively and directly compare the capability for assessments of regional ventilation and pulmonary functional loss in smokers of xenon-ventilation CT obtained with the dual-energy CT (DE-CT) and subtraction CT (Sub-CT) MATERIALS AND METHODS: Twenty-three consecutive smokers (15 men and 8 women, mean age: 69.7±8.7years) underwent prospective unenhanced and xenon-enhanced CTs, the latter by Sub-CT and DE-CT methods, ventilation SPECT and pulmonary function tests. Sub-CT was generated from unenhanced and xenon-enhanced CT, and all co-registered SPECT/CT data were produced from SPECT and unenhanced CT data. For each method, regional ventilation was assessed by using a 11-point scoring system on a per-lobe basis. To determine the functional lung volume by each method, it was also calculated for individual sublets with a previously reported method. To determine inter-observer agreement for each method, ventilation defect assessment was evaluated by using the χ2 test with weighted kappa statistics. For evaluation of the efficacy of each method for pulmonary functional loss assessment, functional lung volume was correlated with%FEV1.

RESULTS: Each inter-observer agreement was rated as substantial (Sub-CT: κ=0.69, p<0.0001; DE-CT: κ=0.64, p<0.0001; SPECT/CT: κ=0.64, p<0.0001). Functional lung volume for each method showed significant to good correlation with%FEV1 (Sub-CT: r=0.72, p=0.0001; DE-CT: r=0.74, p<0.0001; SPECT/CT: r=0.66, p=0.0006).

CONCLUSION: Xenon-enhanced CT obtained by Sub-CT can be considered at least as efficacious as that obtained by DE-CT and SPECT/CT for assessment of ventilation abnormality and pulmonary functional loss in smokers.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Ohno Y, Yoshikawa T, Takenaka D, et al. Xenon-enhanced CT using subtraction CT: Basic and preliminary clinical studies for comparison of its efficacy with that of dual-energy CT and ventilation SPECT/CT to assess regional ventilation and pulmonary functional loss in smokers. Eur J Radiol. 2016. PMID: 28027764. doi:10.1016/j.ejrad.2016.10.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。